I agree that this site is using cookies. You can find further informations here.
X
Testino, Elisa
26  results:
Search for persons X
?
1

Long-Term Efficacy of Mepolizumab at 3 Years in Patients wi..:

Bagnasco, Diego ; Nicola, Stefania ; Testino, Elisa...
Biomedicines.  11 (2023)  9 - p. 2424 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Specific Therapy for T2 Asthma:

Bagnasco, Diego ; Testino, Elisa ; Nicola, Stefania...
Journal of Personalized Medicine.  12 (2022)  4 - p. 593 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Severe asthma: One disease and multiple definitions:

Bagnasco, Diego ; Paggiaro, Pierluigi ; Latorre, Manuela...
World Allergy Organization Journal.  14 (2021)  11 - p. 100606 , 2021
Link: https://doi.org/10.1016/..
 
?
4

The importance of being not significant: Blood eosinophils ..:

Bagnasco, Diego ; Massolo, Alessandro ; Bonavia, Marco...
Allergy.  75 (2020)  6 - p. 1460-1463 , 2020
Link: https://doi.org/10.1111/..
 
?
5

Clinical-economic impact of mepolizumab in patients with se..:

Bagnasco, Diego ; Povero, Massimiliano ; Pradelli, Lorenzo...
World Allergy Organization Journal.  13 (2020)  8 - p. 100376 , 2020
Link: https://doi.org/10.1016/..
 
?
6

One year of mepolizumab. Efficacy and safety in real-life i..:

Bagnasco, Diego ; Caminati, Marco ; Menzella, Francesco...
Pulmonary Pharmacology & Therapeutics.  58 (2019)  - p. 101836 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeuti..:

Bagnasco, Diego ; Caminati, Marco ; Ferrando, Matteo...
BioMed Research International.  2018 (2018)  - p. 1-8 , 2018
Link: https://doi.org/10.1155/..
 
?
8

Long-Term Efficacy of Mepolizumab at 3 Years in Patients wi..:

Bagnasco, Diego ; Nicola, Stefania ; Testino, Elisa...
info:eu-repo/semantics/altIdentifier/wos/WOS:001075527000001.  , 2023
Link: https://hdl.handle.net/2..
 
?
9

Long-Term Efficacy of Mepolizumab at 3 Years in Patients wi..:

Bagnasco, Diego ; Nicola, Stefania ; Testino, Elisa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525371/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Long-Term Efficacy of Mepolizumab at 3 Years in Patients wi..:

Bagnasco, Diego ; Nicola, Stefania ; Testino, Elisa...
info:eu-repo/semantics/altIdentifier/wos/WOS:001075527000001.  , 2023
Link: https://hdl.handle.net/1..
 
?
11

Severe asthma: One disease and multiple definitions:

Bagnasco, Diego ; Paggiaro, Pierluigi ; Latorre, Manuela...
info:eu-repo/semantics/altIdentifier/wos/WOS:000724917300002.  , 2021
Link: http://hdl.handle.net/11..
 
?
12

Severe asthma: One disease and multiple definitions:

Bagnasco, Diego ; Paggiaro, Pierluigi ; Latorre, Manuela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609160/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Pharmacokinetics and pharmacodynamics of monoclonal antibod..:

Bagnasco, Diego ; Heffler, Enrico ; Testino, Elisa..
info:eu-repo/semantics/altIdentifier/pmid/30632416.  , 2019
Link: http://hdl.handle.net/11..
 
?
14

The importance of being not significant: blood eosinophils ..:

Bagnasco, Diego ; Massolo, Alessandro ; Bonavia, Marco...
info:eu-repo/semantics/altIdentifier/pmid/31773742.  , 2019
Link: http://hdl.handle.net/23..
 
?
15

Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeuti..:

Bagnasco, Diego ; Caminati, Marco ; Ferrando, Matteo...
info:eu-repo/semantics/altIdentifier/pmid/30519580.  , 2018
Link: http://hdl.handle.net/11..
 
1-15